International Journal of Radiation Oncology*Biology*Physics
Ureter Tolerance in Patients Treated with Stereotactic Body Radiation Therapy on Abdominopelvic Lymph Nodes: Analysis on Dose-related Late Toxicity
June 2025 • Lucy A. van Werkhoven, Chiara Mattioli, Maaike T.W. Milder, Mauro Loi, Joost J. Nuyttens
The incidence of G3 ureteral toxicity after SBRT on A-P LN oligometastases is low (2%). Published dose constraints were violated in 23% of the patients without reported toxicity, suggesting other factors may contribute. Furthermore, no difference was found between the planned and received ureter dose, indicating that the planned dose is a reliable estimate of the dose received.